Troutman Pepper advised Sinclair Research, a preclinical contract research organization (CRO) located in the Midwest, in its sale to Altasciences, an integrated CRO/CDMO offering pharmaceutical and biotechnology companies a seamless solution to early-stage drug development from lead candidate selection to clinical proof of concept. Read a company press release about the transaction.
Sinclair Research is a large nonclinical CRO that offers full-service IND and NDA-enabling toxicology and safety pharmacology services. Built on more than 50 years of experience, Sinclair Research provides services to support biopharmaceutical, animal health, and medical device development programs.
The Troutman Pepper team advising Sinclair Research in the sale was led by Partner Todd Boylan and included Howard Goldberg, Samantha Peruto, and Daisy Flores, among others.